XML 66 R16.htm IDEA: XBRL DOCUMENT v3.20.1
Note 10 - Shareholders' Equity
12 Months Ended
Dec. 31, 2019
Notes to Financial Statements  
Shareholders' Equity and Share-based Payments [Text Block]
10
.     
Shareholders’
Equity
 
Repurchase Program
 
During the year ended
December 31, 2019,
the Company repurchased and retired
683,910
shares of its common stock for
$2,548,000.
During the year ended
December 31, 2018,
the Company repurchased and retired
999,900
shares of its common stock for
$3,580,000.
As of
December 31, 2019,
the Company had
$2,152,000
available to repurchase common shares under the repurchase program.
 
Option
A
ctivity
 
The
2004
Stock Option Plan (the
“2004
Plan”) is an equity compensation plan that provides for grants of stock options to eligible individuals.  The
2004
Plan is intended to recognize the contributions made to the Company by key employees of the Company, provide key employees with additional incentive to devote themselves to the future success of the Company and improve the ability of the Company to attract, retain and motivate individuals.  The
2004
Plan also is intended as an incentive to certain members of the Board of Directors of the Company to continue to serve on the Board of Directors and to devote themselves to the future success of the Company.
 
The
2004
Plan provides for a total of
5,000,000
common shares eligible for issuance.
 
Under the
2004
Plan, approximately
5,009,750
options had been granted as of
December 31, 2019.
Under the
2004
Plan, option grants have a
three
-year vesting period and, since
2005,
expire
no
later than the
fifth
anniversary from the date of grant. The exercise price of the options is determined based on the fair market value of the stock on the date of grant.
 
The following table summarizes option activity for the years ended
December 31, 2019
and
2018:
 
   
 
 
 
 
Weighted
 
   
 
 
 
 
Average
 
   
 
 
 
 
Exercise Price
 
   
Shares
   
Per Option
 
Options outstanding, December 31, 2017
   
884,998
    $
2.26
 
Granted to employees and directors
   
349,750
     
3.27
 
Exercised
   
(211,835
)    
1.86
 
Canceled/expired/forfeited
   
-
     
-
 
Options outstanding, December 31, 2018
   
1,022,913
     
2.69
 
Granted to employees and directors
   
370,000
     
3.59
 
Exercised
   
(66,499
)    
1.96
 
Canceled/expired/forfeited
   
-
     
-
 
Options outstanding, December 31, 2019
   
1,326,414
     
2.97
 
Options exercisable, December 31, 2019
   
694,914
     
2.51
 
 
Stock options to purchase
1,326,414
and
1,022,913
shares of common stock were outstanding as of
December 31, 2019
and
2018,
respectively. All except
455,000
and
145,000
of the stock options, which were anti-dilutive, were included in the computation of the weighted-average number of dilutive common shares outstanding for the years ended
December 31, 2019
and
2018.
 
The fair values of the share-based compensation awards granted were estimated using the Black-Scholes option-pricing model with the following assumptions and weighted average fair values:
 
   
Stock Options
 
   
For the Years Ended December 31,
 
   
2019
   
2018
 
Exercise price
  $
3.59
    $
3.27
 
Risk-free interest rate
   
2.23
%
   
2.73
%
Expected volatility
   
32.17
%
   
57.75
%
Expected life in years
   
4.25
     
4.25
 
Dividend rate
   
-
     
-
 
Black-Scholes fair value
  $
1.06
    $
1.57
 
 
The Company used the Black-Scholes option-pricing model to value the options. The Company uses historical data to estimate the expected term of the options. The risk-free interest rate for periods consistent with the expected term of the award is based on the U.S. Treasury rates in effect at the time of grant. The expected volatility is based on historical volatility. The Company uses an estimated dividend payout ratio of zero, as the Company has
not
paid dividends in the past and, at this time, does
not
expect to do so in the foreseeable future. The Company accounts for option forfeitures as they occur.
 
The following table summarizes information about stock options as of
December 31, 2019:
 
 
 
 
 
 
Options Outstanding
   
Options Exercisable
 
Range of
Exercise
Prices
   
Options
   
Weighted
Average Exercise Price
   
Weighted
Average Remaining Contract Life (in years)
   
Aggregate
Intrinsic
Value
   
Options
   
Weighted
Average Exercise Price
   
Weighted
Average Remaining Contract Life (in years)
   
Aggregate
Intrinsic
Value
 
$1.58
-
$3.90
     
1,326,414
    $
2.97
     
2.84
    $
604,000
     
694,914
    $
2.51
     
2.16
    $
636,000
 
 
The intrinsic value is the amount by which the market value of the underlying common stock exceeds the exercise price of the respective stock options. The aggregate intrinsic value of stock options exercised during the years ended
December 31, 2019
and
2018
was
$121,000
and
$356,000,
respectively.
 
As of
December 31, 2019,
$589,000
of total unrecognized compensation cost related to stock options was expected to be recognized over a weighted-average remaining period of
1.91
years. Cash received from
66,499
options exercised for the year ended
December 31, 2019
was
$130,000.
 
Dividends
 
The holders of the Company’s common stock are entitled to receive such dividends as
may
be declared by the Board of Directors of the Company from time to time to the extent that funds are legally available for payment thereof. The Company has never declared or paid any dividends on any of its outstanding shares of common stock. The Board of Directors’ current policy is
not
to pay dividends but rather to use available funds to repurchase common shares in accordance with the Company’s repurchase program and to fund the continued development and growth of the Company. Consequently, the Company currently has
no
plans to pay cash dividends in the foreseeable future.